SCOPUS 정보 검색 플랫폼

European Journal of Clinical Pharmacology

Volumn 40, Issue 1, 1991, Pages

Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase

(1) Pan, H Y a

a Squibb Inst for Medical Research (United States)

Author keywords

HMG CoA reductase; inhibitors; pravastatin

Indexed keywords

LOW DENSITY LIPOPROTEIN; PRAVASTATIN;

CONFERENCE PAPER; DROWSINESS; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE; LIVER FAILURE; NAUSEA; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RASH; VERTIGO;

ANTICHOLESTEREMIC AGENTS; CHOLELITHIASIS; DRUG INTERACTIONS; HEPTANOIC ACIDS; HUMAN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; LACTATION; LIVER DISEASES; NAPHTHALENES; PRAVASTATIN; REFERENCE VALUES;

EID: 0026062051 PISSN: 00316970 EISSN: 14321041 Source Type: Journal
DOI: 10.1007/BF01409401 Document Type: Article

Times cited : (45)

References (14)

1
- 0010619456
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
- (1981) Proc Natl Acad Sci USA , vol.78 , pp. 1194-1198
- Kovanen, P.T.¹ Bilheimer, D.W.² Goldstein, J.L.³

2
- 0003042048
- Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits
- (1986) Proc Natl Acad Sci USA , vol.83 , pp. 8370-8374
- Ma, P.T.S.¹ Gil, G.² Sudhof, J.C.³

3
- 0023876839
- HMG-CoA reductase inhibitors for treatment of hypercholesterolemia
- (1988) N Engl J Med , vol.319 , pp. 324-332
- Grundy, S.M.¹

4
- 0022485201
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect in various animal species
- (1986) Biochim Biophys Acta , vol.877 , pp. 50-60
- Tsujita, Y.¹ Kuroda, M.² Shimada, Y.³

5
- 0024461808
- Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutarylcoenzyme A reductase on cholesterol biosynthesis in lens
- (1989) J Lipid Res , vol.30 , pp. 1411-1420
- Mosley, S.T.¹ Kalinowski, S.S.² Schafer, B.L.³

6
- 0003340888
- Mechanism of action and differential pharmacology of pravastatin, a hydrophilic and selective HMG-CoA reductase inhibitor
- (1989) Royal Society of Medicine International Congress and Symposium Series , vol.162 , pp. 1-8
- Scott, W.A.¹ Mahoney, E.M.² Mosley, S.T.³

7
- 84935210100
- Pan HY, Willard DA, Morrison RA, et al (1987) Disposition of SQ 31,000 (CS-514), a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Clin Res 35: 794A

8
- 0342414244
- Pharmacokinetics, pharm acodynamics and safety of pravastatin sodium, a potent inhibitor of HMG-CoA reductase, in healthy volunteers
- (1989) Royal Society of Medicine International Congress and Symposium Series , vol.162 , pp. 9-22
- Pan, H.Y.¹ Funke, P.T.² Willard, D.A.³

9
- 84935168828
- Pan HY, Swanson BN, DeVault AR, et al (1989) Antipyrine elimination is not affected by chronic administration of pravastatin (SQ 31,000), a tissue-selective HMG-CoA reductase inhibitor. Clin Res 36:368 A

10
- 0006277284
- Excretion of pravastatin, an HMG-CoA reductase inhibitor, in breast milk of lactating women
- (1988) J Clin Pharmacol , vol.28 , pp. 942
- Pan, H.¹ Fleiss, P.² Moore, L.³

11
- 84935210044
- Comparative pharmacokinetics of pravastatin, an HMG-CoA reductase inhibitor, in healthy elderly and young male subjects
- (1989) J Clin Pharmacol , vol.29 , pp. 848
- Pan, H.¹ Funke, P.² Waclawski, A.³

12
- 0006277284
- Pharmacokinetics of pravastatin, an HMG-CoA reductase inhibitor in healthy female subjects
- (1988) J Clin Pharmacol , vol.28 , pp. 942
- Pan, H.¹ Gourzis, J.² Kassalow, L.³

13
- 84935186122
- Hunninghake D, Goldberg A, Insull W, et al (1988) Pravastatin: a tissue-selective once-daily HMG-CoA reductase inhibitor in the treatment of primary hypercholesterolemia. J Am Coll Cardiol 11: 8 A

14
- 84909850771
- Clinical efficacy of pravastatin
- (1989) Royal Society of Medicine International Congress and Symposium Series , vol.162 , pp. 23-28
- Betteridge, D.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.